Vertex Pharma (VRTX) Announces FDA Approval for ORKAMBI in Children 6-11; Lowers 2016 ORKAMBI Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/17/2024
Go back to Vertex Pharma (VRTX) Announces FDA Approval for ORKAMBI in Children 6-11; Lowers 2016 ORKAMBI Revenue Outlook
September 29, 2016 7:13 AM EDT
Leerink affirms Vertex Pharma (Nasdaq; VRTX) at Outperform following ORKAMBI approval news and lowered revenue outlook issued Wednesday night.
Abakyst Geoffrey... More